Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11899-010-0044-z.pdf
Reference51 articles.
1. Tefferi A: Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 2005, 23(33):8520–8530.
2. Smith RE, Chelmowski MK, Szabo EJ: Myelofibrosis: a review of clinical and pathologic features and treatment. Crit Rev Oncol Hematol 1990, 10(4):305–314.
3. •• Mesa RA, Verstovsek S, Cervantes F, et al.: Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV myelofibrosis), post essential thrombocythemia myelofibrosis (post-ET myelofibrosis), blast phase PMF (PMF-BP): consensus on terminology by the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT). Leuk Res 2007, 31(6):737–740. This paper recommends a standardized, uniform terminology regarding myeloproliferative neoplasms.
4. • Cervantes F, Passamonti F, Barosi G: Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia 2008, 22(5):905–914. This review addresses the recent data about survival and prognosis in myeloproliferative neoplasms.
5. • Kröger N, Mesa RA: Choosing between stem cell therapy and drugs in myelofibrosis. Leukemia 2008, 22(3):474–486. This review discusses in detail the current conventional treatment options and allogeneic stem cell transplantation for patients with myelofibrosis.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis;Journal of Personalized Medicine;2022-04-02
2. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT);American Journal of Hematology;2020-10-27
3. Experiences of allogeneic hematopoietic cell transplantation following non-myeloablative conditioning regimen in severely comorbid patients with myelofibrosis: case series with a patient presenting with extensive extramedullary hematopoiesis;Therapeutic Advances in Hematology;2020-01
4. Síndromes mieloproliferativos;Medicine - Programa de Formación Médica Continuada Acreditado;2016-11
5. Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation;Haematologica;2016-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3